Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure
Iron deficiency (ID) is one of the most common comorbidities in patients with heart failure (HF). ID is a strong independent predictor of outcomes in HF patients. ID reduces quality of life, exercise tolerance, and survival in patients with HF, regardless of anemia status. The latest 2021 gui...
Saved in:
| Main Authors: | I. V. Zhirov, N. V. Safronova, S. N. Tereshchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2022-06-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4940 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenous iron therapy for heart failure and iron deficiency: An updated meta‐analysis of randomized clinical trials
by: Mushood Ahmed, et al.
Published: (2025-02-01) -
Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis
by: Burhanuddin Sohail Rangwala, et al.
Published: (2024-12-01) -
Prevalence and clinical significance of iron deficiency in patients with acute decompensated heart failure
by: E. A. Smirnova, et al.
Published: (2023-09-01) -
Effect of intravenous iron supply in patients with heart failure with reduced ejection fraction – a literature review
by: Katarzyna Dąbek, et al.
Published: (2024-12-01) -
Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience
by: Nikolina Brkić, et al.
Published: (2024-01-01)